Lubnow Matthias, Koch Chiara T, Malfertheiner Maximilian V, Foltan Maik, Philipp Alois, Lunz Dirk, Schlitt Hans J, Brennfleck Frank, Dietl Barbara, Hamer Okka W, Stadlbauer Andrea, Schmid Christof, Zeman Florian, Müller Thomas, Fisser Christoph
Department of Internal Medicine II, University Medical Center Regensburg, 93053 Regensburg, Germany.
Center for Pulmonary Medicine, Hospital Donaustauf, 93093 Donaustauf, Germany.
J Clin Med. 2025 Jan 28;14(3):855. doi: 10.3390/jcm14030855.
Critically ill patients requiring extracorporeal membrane oxygenation (ECMO) have several risk factors to suffer from abdominal compartment syndrome (ACS). Little is known about this subgroup. The aim of this study was to investigate the prevalence and associated factors for ACS in patients requiring ECMO to assess the effect of decompressive laparotomy (DL) and the impact on mortality. This retrospective observational study analyzed adult patients requiring ECMO in four intensive care units at the University Medical Center Regensburg between 01/2010 and 06/2020. Patients with clinically suspected ACS were screened by measuring intra-abdominal pressure (IAP) with the trans-bladder technique. ACS was defined as IAP > 20 mmHg and survival was defined as successful discharge from hospital. The prevalence of ACS in non-ECMO ICU patients was 0.8% (291/36,795) and 2.9% (47/1643) in ECMO patients. In the subgroup of resuscitated ECMO patients, ACS was present in 4.2% (32/766). Procalcitonin was associated with ACS. ECMO patients with ACS receiving DL were significantly more ill compared to those without DL (SOFA score at ICU admission 18 [15; 20], vs. 16 [13; 17], = 0.048). DL decreased IAP and significantly improved ventilation; vasopressor and lactate stabilized within 24 hours. Survival was comparable between the DL and the non-DL groups (11% [1/9] vs. 14% [1/7], = 1.000). ECMO patients are at high risk of developing ACS, even more so for resuscitated patients. This and high procalcitonin may be taken into consideration when screening for ACS. Decompressive laparotomy did improve respiratory compliance and stabilized hemodynamic parameters with low rates of complication. Even though patients that received DL were significantly more ill, the mortality rates were not higher.
需要体外膜肺氧合(ECMO)的重症患者有多种发生腹腔间隔室综合征(ACS)的风险因素。对于这一亚组患者了解甚少。本研究的目的是调查需要ECMO的患者中ACS的患病率及相关因素,以评估减压剖腹术(DL)的效果及其对死亡率的影响。这项回顾性观察性研究分析了2010年1月至2020年6月期间在雷根斯堡大学医学中心四个重症监护病房中需要ECMO的成年患者。通过经膀胱技术测量腹内压(IAP)对临床疑似ACS的患者进行筛查。ACS定义为IAP>20 mmHg,生存定义为成功出院。非ECMO重症监护病房患者中ACS的患病率为0.8%(291/36,795),ECMO患者中为2.9%(47/1643)。在复苏的ECMO患者亚组中,ACS的发生率为4.2%(32/766)。降钙素原与ACS相关。接受DL的ACS的ECMO患者与未接受DL的患者相比病情明显更重(入住重症监护病房时的序贯器官衰竭评估(SOFA)评分:18[15;20],对比16[13;17],P = 0.048)。DL降低了IAP并显著改善了通气;血管活性药物和乳酸水平在24小时内稳定下来。DL组和非DL组的生存率相当(11%[1/9]对比14%[1/7],P = 1.000)。ECMO患者发生ACS的风险很高,复苏患者更是如此。在筛查ACS时可考虑这一点以及高降钙素原。减压剖腹术确实改善了呼吸顺应性并稳定了血流动力学参数,并发症发生率较低。尽管接受DL的患者病情明显更重,但死亡率并未更高。